Biomoneta Avata Rx— 510(k) K251872
Substantially EquivalentBiomoneta Research Private Limited
FDA 510(k) clearance K251872 for Biomoneta Avata Rx, Substantially Equivalent on 2025-11-14. Applicant: Biomoneta Research Private Limited.
Clearance details
- Applicant
- Biomoneta Research Private Limited
- Product code
- Code FRF
- Advisory panel
- General Hospital
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Bengaluru, IN
Data sourced from openFDA. This site is unofficial and independent of the FDA.